Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Mol Cancer Ther. 2016 Dec 21;16(3):440–452. doi: 10.1158/1535-7163.MCT-16-0285

Figure 3. Efficacy of CelePlum-777 compared to nanoliposomes containing individual drugs.

Figure 3

Normal (3A) or melanoma cell lines (3B) were treated with empty liposome, Celecoxib liposome (100 μmol/L), Plumbagin liposome (5 μmol/L), or CelePlum-777 (100 μmol/L Celecoxib + 5 μmol/L Plumbagin) for 24, 48, and 72 hours and cell survival assessed by MTS assay. Data represent averages of at least 3 independent experiments; bars, S.E.M.